Publications by authors named "Da-Sheng Wang"

Claim this Profile
M
Molecular Glues: The Adhesive Connecting Targeted Protein Degradation to the Clinic.
Janet M Sasso, Rumiana Tenchov, DaSheng Wang, Linda S Johnson, Xinmei Wang

Biochemistry· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mantuoluosides A-H, new steroids isolated from the leaves of Datura stramonium L.
Juan Pan, Yan Liu, Si-Yi Wang, Jia-Tong Wu, Ming-Yuan Guo, Da-Sheng Wang

Fitoterapia· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction: Antitumor Effects of a Novel Phenylbutyrate-based Histone Deacetylase Inhibitor, ()-HDAC-42, in Prostate Cancer.
Samuel K Kulp, Chang-Shi Chen, Da-Sheng Wang, Ching-Yu Chen, Ching-Shih Chen

Clin Cancer Res· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma.
Da-Liang Ou, Ying-Chun Shen, Ja-Der Liang, Jun-Yang Liou, Sung-Liang Yu, Da-Sheng Wang

Clin Cancer Res· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide down-regulates the CD20 antigen and antagonizes direct and antibody-dependent cellular cytotoxicity of rituximab on primary chronic lymphocytic leukemia cells.
Rosa Lapalombella, Bo Yu, Georgia Triantafillou, Qing Liu, Jonathan P Butchar, Da-Sheng Wang

Blood· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Higher doses of lenalidomide are associated with unacceptable toxicity including life-threatening tumor flare in patients with chronic lymphocytic leukemia.
Leslie A Andritsos, Amy J Johnson, Gerard Lozanski, William Blum, Cheryl Kefauver, Da-Sheng Wang

J Clin Oncol· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological exploitation of the peroxisome proliferator-activated receptor gamma agonist ciglitazone to develop a novel class of androgen receptor-ablative agents.
Jian Yang, Shuo Wei, Da-Sheng Wang, Yu-Chieh Wang, Samuel K Kulp

J Med Chem· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FTY720 induces apoptosis in hepatocellular carcinoma cells through activation of protein kinase C delta signaling.
Jui-Hsiang Hung, Yen-Shen Lu, Yu-Chieh Wang, Yi-Hui Ma, Da-Sheng Wang

Cancer Res· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor effects of a novel phenylbutyrate-based histone deacetylase inhibitor, (S)-HDAC-42, in prostate cancer.
Samuel K Kulp, Chang-Shi Chen, Da-Sheng Wang, Ching-Yu Chen, Ching-Shih Chen

Clin Cancer Res· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of small-molecule cyclin D1-ablative agents.
Jui-Wen Huang, Chung-Wai Shiau, Jian Yang, Da-Sheng Wang, Hao-Chieh Chiu

J Med Chem· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
alpha-Tocopheryl succinate induces apoptosis in prostate cancer cells in part through inhibition of Bcl-xL/Bcl-2 function.
Chung-Wai Shiau, Jui-Wen Huang, Da-Sheng Wang, Jing-Ru Weng, Chih-Cheng Yang

J Biol Chem· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-based optimization of phenylbutyrate-derived histone deacetylase inhibitors.
Qiang Lu, Da-Sheng Wang, Chang-Shi Chen, Yuan-Dong Hu, Ching-Shih Chen

J Med Chem· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis